Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elevated Health vs Ilant Health

Elevated Health
Graded #283

Higher grade

vs+5
Ilant Health
Graded #407

Lower grade

The verdict

Elevated Health takes it — 61.8/100 to 56.8/100.

Elevated Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Elevated Health offers compounded semaglutide ($176/mo) and compounded tirzepatide ($238/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIlant Health +8
37
45
Dose & formulationElevated Health +48
88
40
Clinical oversightIlant Health +9
74
83
Labs & monitoringIlant Health +9
52
61
FulfillmentEven
62
62
Contract termsElevated Health +6
61
55
Elevated Health · left barIlant Health · right bar

The numbers

MetricElevated HealthIlant Health
WeighScore61.8/10056.8/100
GradeCC
Scorecard rank#283#407
Semaglutide$296/mo (compounded)Not disclosed
Tirzepatide$359/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Elevated Health

Graded #283 · C

Strengths

  • $100 off first month
  • Oral semaglutide option
  • Competitive pricing — compounded semaglutide from $187/mo (12-month plan), tirzepatide from $235/mo

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity or address disclosed
  • State availability not disclosed
  • Shopify storefront — few clinical infrastructure signals
Ilant Health

Graded #407 · C

Strengths

  • Value-based, outcomes-driven obesity care model
  • Includes GLP-1 medications with transparent drug pricing for sponsors
  • Care team of board-certified obesity providers and behavioral specialists
  • Dietitians and peer navigators support adherence
  • Data-driven stratification targets the right interventions

Where it loses points

  • Distributed via employers and health plans, not direct cash-pay
  • Individuals generally cannot enroll without sponsor coverage
  • No public consumer pricing for GLP-1
  • Access gated behind organizational buyers
  • Not suited to consumers wanting direct-to-door GLP-1

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard